We are live on ! Find out more
NRC icon

NRC Health Common Stock

138 hedge funds and large institutions have $273M invested in NRC Health Common Stock in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 40 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 40

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

1% more funds holding

Funds holding: 136138 (+2)

0% more call options, than puts

Call options by funds: $7K | Put options by funds: $7K

2% less capital invested

Capital invested by funds: $280M → $273M (-$6.8M)

1.02% less ownership

Funds ownership: 51.1%50.08% (-1%)

Holders
138
Holders Change
+2
Holders Change %
+1.47%
% of All Funds
1.98%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
52
Reduced
40
Closed
19
Calls
$7K
Puts
$7K
Net Calls
Net Calls Change
+$4K

NRC Hedge Fund Activity: Q3 2024 in Review

138 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q3 2024, worth a combined $273M — down 2.4% from $280M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new NRC positions and 19 closed out — a net gain of 3 holders — while 52 added to existing stakes and 40 trimmed.

The largest buyer was Hotchkis & Wiley Capital Management, opening a new position worth an estimated $3.12M. The largest seller was Invesco, cutting an estimated $5.98M.

  • 138 institutional investors held NRC Health Common Stock (NRC) as of Q3 2024, up from 136 in Q2 2024.
  • Funds reported $273M of NRC Health Common Stock stock for Q3 2024, down 2.4% quarter-over-quarter.
  • 22 funds opened new NRC Health Common Stock positions in Q3 2024 and 19 closed out, a net change of +3 holders.
  • The largest NRC Health Common Stock buyer in Q3 2024 was Hotchkis & Wiley Capital Management, an estimated $3.12M added.
  • The largest NRC Health Common Stock seller in Q3 2024 was Invesco, an estimated $5.98M sold.

Based on aggregated 13F filings for Q3 2024.